RTW Investments’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.9M Buy
+3,892,926
New +$29.5M 0.33% 51
2019
Q4
Sell
-9,703
Closed -$1.5M 66
2019
Q3
$1.5M Buy
9,703
+21
+0.2% +$2.38K 0.09% 55
2019
Q2
$835K Buy
9,682
+226
+2% +$24.6K 0.04% 50
2019
Q1
$1.3M Buy
9,456
+556
+6% +$139K 0.09% 47
2018
Q4
$3.58M Sell
8,900
-8,588
-49% -$4.04M 0.33% 37
2018
Q3
$12.4M Sell
17,488
-27,563
-61% -$17.3M 0.74% 27
2018
Q2
$22.8M Hold
45,051
1.64% 14
2018
Q1
$4.61M Buy
+45,051
New +$15.2M 0.44% 30

Other funds holding SLDB

RTW Investments's SLDB Position: Q2 2026 in Review

RTW Investments opened a new position in Solid Biosciences (SLDB) in Q2 2026: 3,892,926 shares worth $38.9M. The stake represents 0.33% of the portfolio and ranks #51 among its holdings. This is a return to the name: RTW Investments previously reported a position in SLDB as recently as Q3 2019.

RTW Investments first reported a position in SLDB in Q1 2018 and has held it in 8 quarters since. 156 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • RTW Investments held 3,892,926 shares of Solid Biosciences worth $38.9M as of Q2 2026.
  • Solid Biosciences was a new RTW Investments position in Q2 2026.
  • Solid Biosciences made up 0.33% of RTW Investments's portfolio in Q2 2026, its #51 holding.
  • RTW Investments first reported a position in Solid Biosciences in Q1 2018 and has held it in 8 quarters since.
  • 156 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on RTW Investments's 13F filing for Q2 2026, filed 14 Aug 2026.